Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ESMO 2016 /
Carcinoid syndrome

7th - 11th Oct 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 12.10.16
Views: 1910

Dr Rachel Riechelmann - Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil

Dr Riechelmann speaks with ecancertv at ESMO 2016 about carcinoid syndrome, which results from carcinoid tumour invasion of organ sites and stimulation of the release of hormones.

She describes the symptoms and impacts of carcinoid syndrome on patients quality of life, and introduces her review of current literature into understanding of the disease.

Dr Riechelmann calls for studies into the mechanistic action and incidence of carcinoid syndrome, rather than relying on retrospective analyses.

Read Dr Riechelmann’s article "Complications from carcinoid syndrome: review of the current evidence" here

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation